Pneumonia risk signals and their potential for precision medicine

The largest ever genomic study of pneumonia has identified the genetic risk signals of the disease, paving the way for potential new treatments and the use of precision medicine.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup